Abstract
Small gastrointestinal stromal tumors (GISTs) (<3 cm) occasionally are found in the stomach during endoscopy. There is no consensus about the surgical management of these small tumors, although this clinical issue is crucial because some of the tumors show unexpected malignant behavior. In this study, we evaluated the clinical management of patients with gastric GISTs who underwent surgical resection. Altogether, 31 patients with gastric GISTs were examined retrospectively. Surgical resection was fundamentally indicated for the patients with gastric GISTs suspected to be malignant by endoscopy or endoscopic ultrasonography (EUS). The malignant grade of the GISTs was evaluated by the mitotic rate, tumor size, and MIB-1 index. EUS was useful for differentiating benign from malignant GISTs; but by limiting the study to patients with small tumors (<3 cm), the diagnostic value of EUS was not satisfactory for defining the surgical indication. Tumors that were <50 mm were successfully treated by laparoscopic surgery. Of the 31 patients, 4 had a relapse of the disease, and 1 of those 4 patients had a small tumor (30 mm). All of the recurrences were classified in the high risk category. Surgery is indicated for gastric GISTs that are ≥20 mm or are suspected to be malignant based on EUS findings. Laparoscopic resection is feasible and is recommended as the treatment of choice for patients with tumors < 50 mm. Risk assessment can be most useful for predicting recurrence.
Similar content being viewed by others
References
Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577–580
Sircar K, Hewlett BR, Huizinga JD, et al. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999;23:377–389
Pidhorecky I, Cheney RT, Kraybill WG, et al. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000;7:705–712
Seidal T, Edvardsson H. Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours. Histopathology 1999;34:416–424
Fletcher CDM, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459–465
Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal tumors. Lancet Oncol 2002;3:655–664
Kimata M, Kubota T, Otani Y, et al. Gastrointestinal stromal tumors treated by laparoscopic surgery: report of three cases. Surg Today 2000;30:177–180
Basso N, Rosato P, De Leo A, et al. Laparoscopic treatment of gastric stromal tumors. Surg Endosc 2000;14:524–526
Walsh RM, Ponsky J, Brody F, et al. Combined endoscopic/laparoscopic intragastric resection of gastric stromal tumors. J Gastrointest Surg 2003;7:386–392
Amin MB, Ma CK, Linden MD, et al. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Am J Clin Pathol 1993;100:428–432
Taniguchi E, Kamiike W, Yamanishi H, et al. Laparoscopic intragastric surgery for gastric leiomyoma. Surg Endosc 1997;11:287–289
Chak A, Canto MI, Rosch T, et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastroenterol. Endosc.1997;45:468–473
Yasuda K, Nakajima M, Yoshida S, et al. The diagnosis of submucosal tumors of the stomach by endoscopic ultrasonography. Gastroenterol Endosc 1989;35:10–15
Rosch T, Lorenz R, Dancygier H, et al. Endosonographic diagnosis of submucosal upper gastrointestinal tract tumors. Scand J Gastroenterol 1992;27:1–8
Yamada Y, Kida M, Sakaguchi T. A study on myogenic tumors of the upper gastrointestinal tract by endoscopic ultrasonography: with special reference to the differential diagnosis of benign and malignant lesions. Dig Endosc 1992;4:396–408
Terashita S, Tanimura H, Nagai Y, et al. Clinical evaluation of endoscopic ultrasonography in the differential diagnosis for submucosal tumor of gastrointestinal tract. Gastroenterol Endosc 1992;34:342–351
Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30:1213–1220
Vander Noot MR 3rd, Eloubeidi MA, et al. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2004;102:157–163
Gu M, Ghafari S, Nguyen PT, Lin F. Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound-guided fine-needle aspiration biopsy: cytomorphologic and immunohistochemical study of 12 cases. Diagn Cytopathol 2001;25:343–350
Katai H, Sasako M, Sano T, et al. Surgical treatment for gastric leiomyosarcoma. Ann Chir Gynaecol 1998;87:293–296
Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus. Am J Surg Pathol 2001;25:1121–1131
Hasegawa T, Matsuno Y, Shimoda T, et al. Gastrointestinal stromal tumor: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002;33:669–676
DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51–58
Lehnet T. Gastrointestinal sarcoma (GIST): a review of surgical management. Ann Chir Gynaecol 1998;87:297–305
Blanke CD, Eisenberg BL, Heinrich MC. Gastrointestinal stromal tumors. Curr. Treat. Options Oncol 2001;2:485–491
Yoshida M, Otani Y, Ohgami M, et al. Surgical management of gastric leiomyosarcoma: evaluation of the propriety of laparoscopic wedge resection. World J Surg 1997;21:440–443
Kimura H, Yonemura Y, Kadoya N, et al. Prognostic factors in primary gastrointestinal leiomyosarcoma: a retrospective study. World J Surg 1991;15:771–776
Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas: implications for surgical management and staging. Ann Surg 1992;215:68–77
Toquet C, Le Neel JC, Guillou L, et al. Elevated (> or = 10%) MIB-1 proliferative index correlates with poor outcome in gastric stromal tumor patients: a study of 35 cases. Dig Dis Sci 2002;47:2247–2253
Fujimoto Y, Nakanishi Y, Yoshimura K, et al. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 2003;6:39–48
Özgüç H, Yilmazlar T, Yerci Ö, et al. Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential. J Gastrointest Surg 2005;9:418–429
Wong NA, Young R, Malcomson RD, et al. Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 2003;43:118–126
Kim TW, Lee H, Kang YK, et al. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res 2004;10:3076–3081
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iwahashi, M., Takifuji, K., Ojima, T. et al. Surgical Management of Small Gastrointestinal Stromal Tumors of the Stomach. World J. Surg. 30, 28–35 (2006). https://doi.org/10.1007/s00268-005-7944-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-005-7944-4